Literature DB >> 11498295

Th1/Th2 effector choice in parasitic infection: decision making by committee.

D Jankovic1, A Sher, G Yap.   

Abstract

Parasitic infections frequently result in highly polarized CD4+ T cell responses characterized by dominant Th1 or Th2 cytokine production profiles. Although previously thought to be strictly dependent on signaling by the differentiative cytokines, IL-12 and IL-4, recent data indicate that this polarization may be primarily decided instead by a series of different factors intrinsic to the pathogen-antigen-presenting-cell interaction that influence T cell priming.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11498295     DOI: 10.1016/s0952-7915(00)00234-x

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  25 in total

Review 1.  Immunogenetics and the design of Plasmodium falciparum vaccines for use in malaria-endemic populations.

Authors:  Magdalena Plebanski; Owen Proudfoot; Dodie Pouniotis; Ross L Coppel; Vasso Apostolopoulos; Graham Flannery
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

2.  Helminth regulation of host IL-4Ralpha/Stat6 signaling: mechanism underlying NOS-2 inhibition by Trichinella spiralis.

Authors:  Ka Bian; Meng Zhong; Yael Harari; Mildred Lai; Norman Weisbrodt; Ferid Murad
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-01       Impact factor: 11.205

3.  Immunogenicity of two Echinococcus granulosus antigens EgA31 and EgTrp in mice.

Authors:  M Fraize; M E Sarciron; S Azzouz; N Issaadi; G Bosquet; A F Petavy
Journal:  Parasitol Res       Date:  2005-04-12       Impact factor: 2.289

4.  Humoral and cellular immune responses in BALB/c and C57BL/6 mice immunized with cytoplasmic (CRA) and flagellar (FRA) recombinant repetitive antigens, in acute experimental Trypanosoma cruzi infection.

Authors:  Valéria R A Pereira; Virginia M B Lorena; Mineo Nakazawa; Carlos F Luna; Edimilson D Silva; Antonio G P Ferreira; Marco Aurélio Krieger; Samuel Goldenberg; Milena B P Soares; Eridan M Coutinho; Rodrigo Correa-Oliveira; Yara M Gomes
Journal:  Parasitol Res       Date:  2005-04-27       Impact factor: 2.289

Review 5.  DNA repair pathways in trypanosomatids: from DNA repair to drug resistance.

Authors:  Marie-Michelle Genois; Eric R Paquet; Marie-Claude N Laffitte; Ranjan Maity; Amélie Rodrigue; Marc Ouellette; Jean-Yves Masson
Journal:  Microbiol Mol Biol Rev       Date:  2014-03       Impact factor: 11.056

6.  Defenses of susceptible and resistant Chinook salmon (Oncorhynchus tshawytscha) against the myxozoan parasite Ceratomyxa shasta.

Authors:  Sarah J Bjork; Yong-An Zhang; Charlene N Hurst; Maria E Alonso-Naveiro; Julie D Alexander; J Oriol Sunyer; Jerri L Bartholomew
Journal:  Fish Shellfish Immunol       Date:  2014-01-08       Impact factor: 4.581

Review 7.  New insights into T cell biology and T cell-directed therapy for autoimmunity, inflammation, and immunosuppression.

Authors:  Scott M Steward-Tharp; Yun-jeong Song; Richard M Siegel; John J O'Shea
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

8.  A comparison of multiplex suspension array large-panel kits for profiling cytokines and chemokines in rheumatoid arthritis patients.

Authors:  Imran H Khan; V V Krishnan; Melanie Ziman; Kim Janatpour; Ted Wun; Paul A Luciw; Joseph Tuscano
Journal:  Cytometry B Clin Cytom       Date:  2009-05       Impact factor: 3.058

9.  Host response of platelet-activating factor receptor-deficient mice during pulmonary tuberculosis.

Authors:  Sebastiaan Weijer; Jaklien C Leemans; Sandrine Florquin; Takao Shimizu; Satoshi Ishii; Tom van der Poll
Journal:  Immunology       Date:  2003-08       Impact factor: 7.397

10.  Integrated cytokine and metabolic analysis of pathological responses to parasite exposure in rodents.

Authors:  Jasmina Saric; Jia V Li; Jonathan R Swann; Jürg Utzinger; Gail Calvert; Jeremy K Nicholson; Stephan Dirnhofer; Maggie J Dallman; Magda Bictash; Elaine Holmes
Journal:  J Proteome Res       Date:  2010-05-07       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.